These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20404614)

  • 1. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
    Kennedy AS; Salem R
    Cancer J; 2010; 16(2):163-75. PubMed ID: 20404614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
    Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
    Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
    Uthappa MC; Ravikumar R; Gupta A
    Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the art: radiolabeled microspheres treatment for liver malignancies.
    Deleporte A; Flamen P; Hendlisz A
    Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
    J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
    J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
    Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
    Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
    Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
    Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
    Bangash AK; Atassi B; Kaklamani V; Rhee TK; Yu M; Lewandowski RJ; Sato KT; Ryu RK; Gates VL; Newman S; Mandal R; Gradishar W; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 May; 18(5):621-8. PubMed ID: 17494843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS; Kennedy AS; Thomadsen B
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
    Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S; Lau WY; Leung WT
    Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
    Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.
    Cao CQ; Yan TD; Bester L; Liauw W; Morris DL
    Br J Surg; 2010 Apr; 97(4):537-43. PubMed ID: 20205229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.